Home

EVAg

European Virus Archive - GLOBAL
  • Contact Us
  • FAQs
  • Login / Register
  • RSS
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Home
  • Portal
  • The project
    • Concept & Approach
    • News
    • Publications
    • Newsletters
  • Partners
  • Industrials
  • Home
  • The project
  • News

News

Latest news

  • January 12, 2023

    Sven on the Spotlight !

    EVAg
  • January 12, 2023

    What would happen without biobanks?

  • January 12, 2023

    Beatrice Boniotti is developing a swine enteroid model! …A what?

    EVAg
  • January 12, 2023

    An insight into our decision-making process….when it comes to vaccination.

    EVAg
  • September 14, 2022

    What is a biobank and how does it work?

  • September 14, 2022

    Interesting facts on plant viruses: what I learned from Eric Verdin

    EVAg
  • September 14, 2022

    Training workshop on Diagnostics for African researchers

    EVAg
  • July 29, 2022

    ISIDORe: A New Approach to Pandemic Preparedness Research in Europe

    EVAg
  • June 2, 2022

    Monkeypox virus and other Orthopoxviruses collection

    Monkeypox virus
  • September 30, 2020

    SARS-CoV-2: antiviral compounds test results

    EVAg
  •  
  • 1 of 3
  • next ›
Hotline

EVAg Hotline

Any institution that requires guidance on the actions that should be taken for recording, reporting, investigating security breaches and to ensure the safety of all staff, can be supported by EVAg

For tropical and RG4 viruses

In the event of a major biological incident regarding tropical (exotic) viruses or Risk Group 4 viruses, contact

Bernard Nocht Institute by clicking here

For other human viruses of medical importance

The Charité University Berlin (CUB) is in charge of our hotline dedicated to other human viruses of medical importance

Contact the CUB here

For veterinary pathogens of economic importance

In case of biological events involving such pathogens contact
The Animal and Plant Health Agency here

or
+44 1932 357840

EVAg

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 871029


H2020 - grant agreement n°871029-EVA-GLOBAL
  • FAQs
  • Sitemap
  • Legal mentions
  • Newsletter
  • Contact
  • RSS
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
The EVA-GLOBAL community supports fair and equitable benefit sharing as conceived in various United Nations frameworks. The consortium is actively implementing a CBD/Nagoya Protocol compliance strategy. Learn more ...